valproic acid has been researched along with Cachexia in 2 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Cachexia: General ill health, malnutrition, and weight loss, usually associated with chronic disease.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with valproic acid decreases muscle myostatin levels and enhances both follistatin expression and the inactivating phosphorylation of GSK-3beta, while these parameters are not affected by trichostatin-A." | 1.35 | Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice. ( Baccino, FM; Bonelli, G; Bonetto, A; Costelli, P; Minero, VG; Penna, F; Reffo, P, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sun, R | 1 |
Zhang, S | 1 |
Hu, W | 1 |
Lu, X | 1 |
Lou, N | 1 |
Yang, Z | 1 |
Chen, S | 1 |
Zhang, X | 1 |
Yang, H | 1 |
Bonetto, A | 1 |
Penna, F | 1 |
Minero, VG | 1 |
Reffo, P | 1 |
Bonelli, G | 1 |
Baccino, FM | 1 |
Costelli, P | 1 |
2 other studies available for valproic acid and Cachexia
Article | Year |
---|---|
Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Topics: Adenocarcinoma; Animals; Binding Sites; Cachexia; Carcinoma, Lewis Lung; CCAAT-Enhancer-Binding Prot | 2016 |
Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice.
Topics: Animals; Cachexia; Colonic Neoplasms; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme I | 2009 |